26 May 2013
Keywords: sepracor, incontinence, drug, cleared, trials, been, given
Article | 09 December 1996
- Sepracor has been given US approval to begin Phase I testing of its
singe-isomer drug S-oxybutynin for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 March 1997
24 May 2013
© 2013 thepharmaletter.com